Overview

Extracorporal Photopheresis Pilot Study

Status:
Unknown status
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allowed it: 2 ECP per week the first 2 weeks, and 1 ECP per week during 1 month. Total = 8 ECP after transplantation.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Hospices Civils de Lyon
Treatments:
Methoxsalen